ArticleJHEP reports : innovation in hepatology2026

Performance of reMELD-Na as a predictor of short-term mortality in patients with cirrhosis and ascites.

Stefanie Quickert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.